These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
180 related items for PubMed ID: 11956813
1. Genes involved in hepatocellular carcinoma: deregulation in cell cycling and apoptosis. Tannapfel A, Wittekind C. Virchows Arch; 2002 Apr; 440(4):345-52. PubMed ID: 11956813 [Abstract] [Full Text] [Related]
2. Alterations of p53, Bcl-2, and hMSH2 protein expression in the cirrhotic, macroregenerative, dysplastic nodules and hepatocellular carcinomas in Upper Egypt. Hussein MR. Liver Int; 2004 Dec; 24(6):552-60. PubMed ID: 15566504 [Abstract] [Full Text] [Related]
5. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases. Yeh MM, Larson AM, Campbell JS, Fausto N, Rulyak SJ, Swanson PE. Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450 [Abstract] [Full Text] [Related]
8. Immunohistochemical analysis and mutational analyses of beta-catenin, Axin family and APC genes in hepatocellular carcinomas. Ishizaki Y, Ikeda S, Fujimori M, Shimizu Y, Kurihara T, Itamoto T, Kikuchi A, Okajima M, Asahara T. Int J Oncol; 2004 May; 24(5):1077-83. PubMed ID: 15067328 [Abstract] [Full Text] [Related]
11. Survivin (BIRC5) cell cycle computational network in human no-tumor hepatitis/cirrhosis and hepatocellular carcinoma transformation. Wang L, Huang J, Jiang M, Sun L. J Cell Biochem; 2011 May; 112(5):1286-94. PubMed ID: 21312234 [Abstract] [Full Text] [Related]
12. Proliferative drive and liver carcinogenesis: too much of a good thing? Teoh NC. J Gastroenterol Hepatol; 2009 Dec; 24(12):1817-25. PubMed ID: 20002941 [Abstract] [Full Text] [Related]
16. Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling. Nam SW, Park JY, Ramasamy A, Shevade S, Islam A, Long PM, Park CK, Park SE, Kim SY, Lee SH, Park WS, Yoo NJ, Liu ET, Miller LD, Lee JY. Hepatology; 2005 Oct; 42(4):809-18. PubMed ID: 16175600 [Abstract] [Full Text] [Related]
17. Different levels of p53 induced either apoptosis or cell cycle arrest in a doxycycline-regulated hepatocellular carcinoma cell line in vitro. Lai PB, Chi TY, Chen GG. Apoptosis; 2007 Feb; 12(2):387-93. PubMed ID: 17191126 [Abstract] [Full Text] [Related]
18. TIP30 mutant derived from hepatocellular carcinoma specimens promotes growth of HepG2 cells through up-regulation of N-cadherin. Jiang C, Pecha J, Hoshino I, Ankrapp D, Xiao H. Cancer Res; 2007 Apr 15; 67(8):3574-82. PubMed ID: 17440068 [Abstract] [Full Text] [Related]
19. [Molecular biology and hepatocellular carcinoma: current status and future prospects]. Saffroy R, Pham P, Lemoine A, Debuire B. Ann Biol Clin (Paris); 2004 Apr 15; 62(6):649-56. PubMed ID: 15563423 [Abstract] [Full Text] [Related]
20. An update on the molecular genetics of hepatocellular carcinoma. Suriawinata A, Xu R. Semin Liver Dis; 2004 Feb 15; 24(1):77-88. PubMed ID: 15085488 [Abstract] [Full Text] [Related] Page: [Next] [New Search]